Oral contraceptives may reduce bone loss in premature ovarian sufficiency (1)
Potential obesity treatment may increase sepsis risk (1)

New COVID-19 drug to be trialled in UK hospitals (1)

24 Jun 2020

UK hospitals are trialling a new drug, TRV027, that aims to restore the balance between the two hormones, angiotensin II and angiotensin 1-7, to help prevent blood clots and lung damage caused by COVID-19.

Science Focus

Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read